News
News
- Zenith Epigenetics Announces Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol Myers Squibb’s Immune Checkpoint Inhibitor OPDIVO
02/22/2022 / 13:15 - GlobeNewswire - Decodable Closes $20M Round for Real-time Data Engineering Led by Venrock and Bain Capital Ventures
02/22/2022 / 13:00 - GlobeNewswire - BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Against Cancer
02/21/2022 / 19:25 - GlobeNewswire - Tudor Tech and Qylur Announce Strategic Alliance and Vision for an Integrated City-Scale Solution Portfolio
02/21/2022 / 06:00 - GlobeNewswire - WISMOlabs and Wizmo Elevate Package Tracking
02/18/2022 / 15:00 - GlobeNewswire - Dr. Pan Zheng of OncoC4 is Inducted Into the 2022 College of Fellow of American Institute for Medical and Biological Engineering (AIMBE)
02/18/2022 / 13:00 - GlobeNewswire - Chuy’s Holdings, Inc. Announces Fourth Quarter and Fiscal Year 2021 Financial Results
02/17/2022 / 22:05 - GlobeNewswire - Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of C3.ai, Inc. (NYSE: AI) Investors
02/17/2022 / 00:42 - GlobeNewswire - InflaRx Reports Progress in Ongoing Phase II Clinical Trial with Vilobelimab in Cutaneous Squamous Cell Carcinoma
02/16/2022 / 13:30 - GlobeNewswire - BioXcel Therapeutics Presents Positive Data from Phase 2 Trial of BXCL701 in Aggressive Forms of Prostate Cancer at 2022 ASCO Genitourinary Cancers Symposium
02/14/2022 / 23:00 - GlobeNewswire
Real-time